XML 22 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation
3 Months Ended
Oct. 29, 2016
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
5. Stock-Based Compensation

The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 were as follows (in thousands):

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Stock-based compensation expense by type:
            
Stock options
 
$
-
  
$
16
  
$
384
  
$
375
 
Restricted stock unit awards, including performance-based
  
629
   
815
   
3,237
   
3,980
 
Employee stock purchases
  
22
   
23
   
80
   
81
 
Director deferred compensation
  
24
   
18
   
70
   
53
 
Total stock-based compensation expense
  
675
   
872
   
3,771
   
4,489
 
Income tax benefit recognized
  
240
   
316
   
1,363
   
1,645
 
Stock-based compensation expense, net of income tax
 
$
435
  
$
556
  
$
2,408
  
$
2,844
 
 
In the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015, we granted the following equity awards:

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Stock options
  
-
   
1,515
   
36,359
   
21,743
 
Restricted stock unit awards
  
-
   
-
   
100,775
   
69,529
 
Performance-based restricted stock unit awards
  
-
   
-
   
45,300
   
29,300
 
Deferred stock units
  
588
   
500
   
14,744
   
12,128
 

At October 29, 2016, the total compensation costs, related to nonvested restricted stock unit awards not yet recognized was $8.7 million and the weighted-average period over which such awards are expected to be recognized was 2.4 years.  There are no future compensation costs related to nonvested stock options to be recognized at October 29, 2016.

Under the 2012 Non-Employee Director Equity Plan (2012 Plan), no shares of our common stock were awarded during the thirteen weeks ended October 29, 2016 and October 31, 2015.  A total of 2,851 and 1,981 shares of our common stock were awarded during the thirty-nine weeks ended October 29, 2016 and October 31, 2015, respectively, as part of the annual equity award to directors in the first quarter.

There were no stock options granted during the thirteen weeks ended October 29, 2016.  The weighted-average grant date fair value of stock options granted during the thirteen weeks ended October 31, 2015 was $10.52 per shares.  The weighted-average grant date fair value of stock options granted during the thirty-nine weeks ended October 29, 2016 and October 31, 2015 was $10.56 and $17.23 per share, respectively.

Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:

  
Thirteen Weeks Ended
  
Thirty-Nine Weeks Ended
 
  
October 29, 2016
  
October 31, 2015
  
October 29, 2016
  
October 31, 2015
 
Shares purchased
  
3,236
   
3,114
   
11,874
   
8,605
 
Average price per share
 
$
29.29
  
$
29.76
  
$
27.66
  
$
36.66
 
Weighted average fair value at grant date
 
$
7.25
  
$
10.01
  
$
6.94
  
$
10.35